SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 177 filers reported holding SYNDAX PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,224,846 | -25.8% | 773,061 | +6.9% | 2.04% | -13.5% |
| Q2 2023 | $15,133,667 | +4.9% | 723,061 | +5.9% | 2.36% | -2.0% |
| Q1 2023 | $14,426,248 | -20.2% | 683,061 | -3.9% | 2.41% | -37.9% |
| Q4 2022 | $18,083,777 | -8.5% | 710,561 | -13.6% | 3.88% | +41.4% |
| Q3 2022 | $19,769,000 | -9.8% | 822,696 | -27.8% | 2.74% | +17.0% |
| Q2 2022 | $21,921,000 | -1.3% | 1,139,329 | -10.8% | 2.34% | -25.3% |
| Q1 2022 | $22,201,000 | -13.8% | 1,277,413 | +8.6% | 3.14% | +10.8% |
| Q4 2021 | $25,755,000 | +79.6% | 1,176,585 | +56.8% | 2.83% | +135.0% |
| Q3 2021 | $14,344,000 | +52.7% | 750,603 | +37.2% | 1.20% | +89.8% |
| Q2 2021 | $9,395,000 | -34.2% | 547,187 | -14.2% | 0.64% | -42.0% |
| Q1 2021 | $14,268,000 | -14.0% | 638,093 | -14.5% | 1.09% | -25.7% |
| Q4 2020 | $16,589,000 | +120.4% | 745,900 | +46.3% | 1.47% | +98.9% |
| Q3 2020 | $7,528,000 | +58.8% | 510,000 | +59.4% | 0.74% | +65.9% |
| Q2 2020 | $4,742,000 | +534.8% | 320,000 | +369.7% | 0.45% | +379.6% |
| Q1 2020 | $747,000 | -82.4% | 68,134 | -77.2% | 0.09% | -85.6% |
| Q1 2018 | $4,247,000 | +95.1% | 298,472 | +20.1% | 0.64% | +152.9% |
| Q4 2017 | $2,177,000 | -25.1% | 248,472 | 0.0% | 0.26% | -38.6% |
| Q3 2017 | $2,907,000 | -29.8% | 248,472 | -16.1% | 0.42% | -41.0% |
| Q2 2017 | $4,139,000 | +81.4% | 296,310 | +78.2% | 0.70% | +57.6% |
| Q1 2017 | $2,282,000 | +91.4% | 166,310 | 0.0% | 0.45% | +47.7% |
| Q4 2016 | $1,192,000 | -52.7% | 166,310 | 0.0% | 0.30% | -26.3% |
| Q3 2016 | $2,521,000 | – | 166,310 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,600,000 | $52,272,000 | 8.55% |
| Foresite Capital Management IV, LLC | 875,000 | $12,705,000 | 7.06% |
| Aisling Capital Management LP | 1,025,000 | $14,883,000 | 6.13% |
| Saturn V Capital Management LP | 807,969 | $11,731,710 | 4.91% |
| Eversept Partners, LP | 2,596,245 | $37,697,477 | 3.19% |
| ACUTA CAPITAL PARTNERS, LLC | 297,035 | $4,312,948 | 2.89% |
| Paradigm Biocapital Advisors LP | 2,390,077 | $34,703,918 | 2.36% |
| DAFNA Capital Management LLC | 458,373 | $6,655,576 | 2.07% |
| SPHERA FUNDS MANAGEMENT LTD. | 773,061 | $11,224,846 | 2.04% |
| PFM Health Sciences, LP | 2,715,235 | $39,425,212 | 1.86% |